Academic paper
1. Sakai J, Maesaki S..Prevalence, molecular characterization, and drug susceptibility of extended-spectrum β-lactamase-producing Klebsiella pneumoniae, K. quasipneumoniae, and K. variicola in Japan. Microb Pathog 2022 doi: 10.1016/j.micpath.2022.105663.
2. Wada T, Yokota K, Sakai S, Soma M, Kajiyama H, Tarumoto N, Maesaki S, Maeda T, Nagata M, Mimura T. Evaluation of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Levels in Coronavirus Disease Breakthrough Infection During Immunosuppressive Therapy in a Patient with Connective Tissue Disease-Related Interstitial Lung Disease. Mod Rheumatol Case Rep 2022 doi: 10.1093/mrcr/rxac052
3. Montgomery H, Hobbs FDR, Padilla F, Arbetter D, Templeton A, Seegobin S, Kim K, Campos JAS, Arends RH, Brodek BH, Brooks D, Garbes P, Jimenez J, Koh GCKW, Padilla KW, Streicher K, Viani RM, Alagappan V, Pangalos MN, Esser MT; TACKLE study group. Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2022 doi: 10.1016/S2213-2600(22)00180-1.
4. Tokano M, Takagi R, Kawano M, Maesaki S, Tarumoto N, Matsushita S. Signaling via dopamine and adenosine receptors modulate viral peptide-specific and T-cell IL-8 response in COVID-19. Immunol Med 2022 doi: 10.1080/25785826.2022.2079369.
5. Ishibashi N, Pauwels I, Tomori Y, Gu Y, Yamaguchi T, Handa T, Yamaoka M, Ito D, Sakimoto T, Kimura T, Takizawa K, Sato R, Sakashita T, Ooyama A, Versporten A, Goossens H, Tarumoto N, Maesaki S, Tanahashi N. Point Prevalence Surveys of Antimicrobial Prescribing in a Non-Acute Care Hospital in Saitama Prefecture, Japan. Can J Infect Dis Med Microbiol 2022 doi: 10.1155/2022/2497869.
6. Yanagisawa S, Oikawa Y, Takagi S, Horikoshi Y, Satomura A, Imai K, Sakai J, Ishibashi N, Tarumoto N, Iida S, Nakayama H, Haga Y, Maesaki S, Shimada A. HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019. J Diabetes Investig 2022 doi: 10.1111/jdi.13743.
7. Kitagawa Y, Imai K, Matsuoka M, Fukada A, Kubota K, Sato M, Takada T, Noguchi S, Tarumoto N, Maesaki S, Takeuchi S, Maeda T. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. J Med Virol 2022 doi: 10.1002/jmv.27338.
8. Tokano M, Tarumoto N, Imai K, Sakai J, Maeda T, Kawamura T, Seo K, Takahashi K, Yamamoto T, Maesaki S. A Case of Bacterial Meningitis Caused by Bacillus subtilis var. natto. Intern Med 2022 doi: 10.2169/internalmedicine.0768-22.
9. Tokano M, Matsushita S, Takagi R, Yamamoto T, Kawano M. Extracellular adenosine induces hypersecretion of IL-17A by T-helper 17 cells through the adenosine A2a receptor. Brain Behav Immun Health 2022 doi: 10.1016/j.bbih.2022.100544.
10. Tokano M, Kawano M, Takagi R, Matsushita S. Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4+ T-cell hypersecretion of IL-17A and IL-8 in humans. Immunol Med 2022 doi: 10.1080/25785826.2022.2094593/
11. Tokano M, Tarumoto N, Imai K, Sakai J, Kodana M, Naito E, Uchida Y, Nagata M, Maesaki S. A case of Talaromyces marneffei infection that required differentiation from Pneumocystis pneumonia. ID Cases 2022 doi: 10.1016/j.idcr.2022.e01654.
12. Nomura K, Moronuki T, Takeuchi S, Maeda T, Muramatsu T, Iida S, Yamamoto K. Giant mobile thrombi in both the left ventricle and left atrium. J Echocardiogr 2022 doi: 10.1007/s12574-022-00565-w.
13. Nomura K, Moronuki T, Takeuchi S, Maeda T, Toda K, Kobayashi T. Role of Transthoracic Echocardiography in Early Diagnosis of Williams Syndrome in the Neonatal Period. CASE (Phila) 2022 doi: 10.1016/j.case.2022.08.006.
14. Arakawa N, Ushiki A, Abe M, Matsuyama S, Saito Y, Kashiwada T, Horimasu Y, Gemma A, Tatsumi K, Hattori N, Tsushima K, Miyashita K, Saito K, Nakamura R, Toyoda T, Ogawa K, Sato M, Takamatsu K, Mori K, Nishiya T, Izumi T, Ohno Y, Saito Y, Hanaoka M. Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage. Nat Commun 2022 doi: 10.1038/s41467-022-33160-9.
15. Arakawa N, Matsuyama S, Matsuoka M, Kitamura I, Miyashita K, Kitagawa Y, Imai K, Ogawa K, Maeda T, Saito Y, Hasegawa C. Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression. J Pharmacol Sci 2022 doi: 10.1016/j.jphs.2022.06.002.
16. Watanabe M, Ohnishi T, Arai S, Kawakami T, Hayashi K, Ohya K, Hirose S, Yoshinari T, Taharaguchi S, Mekata H, Taniguchi T, Ikarashi Y, Honma M, Goda Y, Hara-Kudo Y. Survival of SARS-CoV-2 and bovine coronavirus on common surfaces of living environments. Sci Rep 2022 doi: 10.1038/s41598-022-14552-9.
17. Yoshinari T, Hayashi K, Hirose S, Ohya K, Ohnishi T, Watanabe M, Taharaguchi S, Mekata H, Taniguchi T, Maeda T, Orihara Y, Kawamura R, Arai S, Saito Y, Goda Y, Hara-Kudo Y. Matrix-Assisted Laser Desorption and Ionization Time-of-Flight Mass Spectrometry Analysis for the Direct Detection of SARS-CoV-2 in Nasopharyngeal Swabs. Anal Chem 2022 doi: 10.1021/acs.analchem.1c04328.
18. Kitagawa Y, Imai K, Matsuoka M, Fukada A, Kubota K, Sato M, Takada T, Noguchi S, Tarumoto N, Maesaki S, Takeuchi S, Maeda T. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. J Med Virol 2022 doi: 10.1002/jmv.27338.
19. Sakai J, Maesaki S. A new real-time quantitative polymerase chain reaction method using locked nucleic acids to detect Neisseria gonorrhoeae infection and point mutation on gyrA associated with quinolone susceptibility. J Microbiol Methods 2022 doi: 10.1016/j.mimet.2022.106619.
20. Imai K, Ishibashi N, Kodana M, Tarumoto N, Sakai J, Kawamura T, Takeuchi S, Taji Y, Ebihara Y, Ikebuchi K, Murakami T, Maeda T, Mitsutake K, Maesaki S. Correction to: Clinical characteristics in blood stream infections caused by Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae: a comparative study, Japan, 2014-2017. BMC Infect Dis 2022 doi: 10.1186/s12879-022-07384-5. Erratum for: BMC Infect Dis. 2019 Nov 8;19(1):946.
21. Iwai M, Fukushima T, Watanabe N, Ohta A, Watanabe A, Takii T, Mitsutake K, Tanaka R, Ebihara Y. Chest Wall Tuberculosis After Bacillus Calmette-Guérin Vaccination. Pediatr Infect Dis J 2022 doi: 10.1097/INF.0000000000003676.
22. Watanabe N, Koyama S, Taji Y, Mitsutake K, Ebihara Y. Direct microorganism species identification and antimicrobial susceptibility tests from positive blood culture bottles using rapid Sepsityper Kit. J Infect Chemother 2022 doi: 10.1016/j.jiac.2021.12.030.
23. Seki M, Hashimoto K, Kondo N, Ohya Y, Kotajima F, Mitsutake K. Sequential Treatment by Antiviral Drugs Followed by Immunosuppressive Agents for COVID-19 Patients with Hematological Malignancy. Infect Drug Resist 2022 doi: 10.2147/IDR.S393198.
24. Karaushi H, Seki M, Miyawaki Y, Watanabe N, Kamoshita F, Mitsutake K. A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen. Am J Case Rep 2022 doi: 10.12659/AJCR.937485.
25. Suga Y, Watanabe N, Suzuki K, Koyama S, Taji Y, Hirano H, Hayashi T, Abe M, Miyazaki Y, Baba Y, Kurita H, Mitsutake K, Ebihara Y. Otitis externa caused by Malassezia slooffiae complicated with mastoiditis: A case report. J Infect Chemother 2023 doi: 10.1016/j.jiac.2022.11.005.
26. Kawamura T, Ono D, Shirai A, Mimura K, Iida S, Saita K, Oka H, Ohno H. Acute femoral osteomyelitis due to hypermucoviscous Klebsiella pneumoniae. ID Cases 2022 doi: 10.1016/j.idcr.2022.e01404.
27. Sawano M, Takeshita K, Ohno H, Oka H. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant. J Breath Res 2022 doi: 10.1088/1752-7163/ac706b.
28. Arashiro T, Arima Y, Muraoka H, Sato A, Oba K, Uehara Y, Arioka H, Yanai H, Yanagisawa N, Nagura Y, Kato Y, Kato H, Ueda A, Ishii K, Ooki T, Oka H, Nishida Y, Stucky A, Miyahara R, Smith C, Hibberd M, Ariyoshi K, Suzuki M. Behavioral factors associated with SARS-CoV-2 infection in Japan. Influenza Other Respir Viruses 2022 Sep doi: 10.1111/irv.12992.
29. Tokano M, Tarumoto N, Imai K, Sakai J, Ishibashi N, Yokota K, Nakayama H, Haga Y, Maesaki S. Timing of Initiation of Methylprednisolone Pulse Therapy in Patients with COVID-19. COVID 2022 https://doi.org/10.3390/covid20500392.
30. Seki M. COVID-19 related secondary bacterial pneumonia~ Comparisons with influenza. Medical Research Archives 2022:10, 2678-2685.
31. Seki M. Thoughts on pneumococcal vaccination for the adult individuals with autoimmune diseases. World J Med Microbiol 2022 doi: 10.31586/wjmm.2022.441
32. Shimada D, Seki M. Clinical Characteristics of Adult COVID-19 Pneumonia and Other Viral Pneumonias: Comparisons of Imaging Findings . Medical Research Archives 2022 https://doi.org/10.18103/mra.v10i10.3134
33. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. Clinical Manifestations of Hospitalized Influenza Patients without Risk Factors: A Prospective Multicenter Cohort Study in Japan via Internet Surveillance. J Infect Chemother 2022 doi: 10.1016/j.jiac.2022.02.001.
34. Miyashita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Kiyota H, Watanabe A. Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia. J Infect Chemother 2022:28:1353-1357.
1. Hosogaya N, Miyazaki T, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Kurokawa T, Kawasaki Y, Hanawa M, Fujii Y, Hanaoka H, Iwami S, Watashi K, Yamagoe S, Miyazaki Y, Wakita T, Izumikawa K, Yanagihara K, Mukae H, Kohno S; Nelfinavir Study Group. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial. Trials 2021;22(1):309.
2.Imai K, Kitagawa Y, Tabata S, Kubota K, Nagura-Ikeda M, Matsuoka M, Miyoshi K, Sakai J, Ishibashi N, Tarumoto N, Takeuchi S, Ito T, Maesaki S, Tamura K, Maeda T. Antibody response patterns in COVID-19 patients with different levels of disease severity in Japan. J Med Virol 2021;93(5):3211-8.
3.Shinkai M, Tsushima K, Tanaka S, Hagiwara E, Tarumoto N, Kawada I, Hirai Y, Fujiwara S, Komase Y, Saraya T, Koh H, Kagiyama N, Shimada M, Kanou D, Antoku S, Uchida Y, Tokue Y, Takamori M, Gon Y, Ie K, Yamazaki Y, Harada K, Miyao N, Naka T, Iwata M, Nakagawa A, Hiyama K, Ogawa Y, Shinoda M, Ota S, Hirouchi T, Terada J, Kawano S, Ogura T, Sakurai T, Matsumoto Y, Kunishima H, Kobayashi O, Iwata S. Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial. Infect Dis Ther 2021;10(4): 2489–509.
4.Ikeda M, Imai K, Kubota K, Noguchi S, Kitagawa Y, Matsuoka M, Tabata S, Miyoshi K, Ito T, Tamura K, Maeda T. Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan. J Med Microbiol 2021 70(4):001291
5.Imai K, Matsuoka M, Tabata S, Kitagawa Y, Ikeda M, Kubota K, Fukada A, Takada T, Sato M, Noguchi S, Takeuchi S, Arakawa N, Miyoshi K, Saito Y, Maeda T. Cross-reactive humoral immune responses against seasonal human coronaviruses in COVID-19 patients with different disease severities. Int J Infect Dis 2021 111:68-75,
6.Ozono S, Zhang Y, Ode H, Sano K, Tan ST, Imai K, Miyoshi K, Kishigami S, Ueno T, Iwatani Y, Suzuki T, Tokunaga K. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat Commun 2021 12(1):848
7.Imai K, Murakami T, Misawa K, Fujikura Y, Kawana A, Tarumoto N, Maesaki S, Maeda T. Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan. Parasitol Int 2021 80:102221
8.Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol. 2021 93(1):99-101
9.Kodana M, Kitagawa Y, Takahashi R, Matsuoka M, Fushimi N, Sakai J, Ishibashi N, Imai K, Takeuchi S, Tarumoto N, Maesaki S, Ikezono T, Maeda T. Concerns about the clinical usefulness of saliva specimens for the diagnosis of COVID-19. J Infect 2021 83(1):119-145
10.Matsuzaki N, Orihara Y, Kodana M, Kitagawa Y, Matsuoka M, Kawamura R, Takeuchi S, Imai K, Tarumoto N, Maesaki S, Maeda T. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test. J Med Virol 2021 93(12):6778-6781
11.Morioka S, Gu Y, Tsuzuki S, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. Determinants of clinic doctors’ attitudes concerning antimicrobial prescription for patients with common colds or bronchitis: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. J Infect Chemother 2021 27(2):131-138
12.Satomura A, Oikawa Y, Nakanishi S, Takagi S, Mizutani G, Iida S, Nakayama H, Haga Y, Nagata M, Maesaki S, Mimura T, Shimada A. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report. Diabetol Int 2021 12(4):1-6
13.Mimura K, Oka H, Sawano M. A perspective on hospital-acquired (nosocomial) infection control of COVID-19: usefulness of spatial separation between wards and airborne isolation unit. J Breath Res 2021 15(4).
14.Nozaki Y, Ono D, Yamamoto K, Mimura K, Sasaki M, Horino A, Ohno H, Oka H. A case of renal abscess and bacteremia caused by Burkholderia pseudomallei that was first unidentifiable by matrix-assisted laser desorption ionization-time of flight mass spectrometry in a Japanese-man. J Infect Chemother 2021 27(11):1653-1657
15.Watanabe T, Koyama S, Tabira M, Yoshitake A, Mitsutake K, Ebihara Y. Infected aortic aneurysm caused by Streptococcus pyogenes: A case report. J Infect Chemother27:647-649, 2021
16.Seki M. Mechanisms and managements of influenza and its related pneumonia。Medical Research Archives,2021 9(7), 2486-2507.
16.Seki M, Takano K, Hariu M, Kamioka Y, Watanabe Y, An adolescent case of influenza-related pulmonary atelectasis. Global Journal of Medical Case Reports 2021, 1, 8-12. DOI: 10.31586/gjmcr.2021.010103
17.Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. Clinical Manifestations of Adult Patients Requiring Influenza-Associated Hospitalization: A Prospective Multicenter Cohort Study in Japan via Internet Surveillance. J Infect Chemother. 2021, 27(3):480-485. doi: 10.1016/j.jiac.2020.10.021.
18.Watanabe Y, Kamioka Y, Seki M. Rhinovirus-infected patients in the COVID-19 pandemic period. Infect Drug Resist 2021 DOI https://doi.org/10.2147/IDR.S300001
19.Kashiwagura S, Kamioka Y, Seki M, Koshika R, Okada K, Analysis of risk factors associated with reduced trough concentrations of vancomycin in relation to renal function in a tertiary hospital in Japan. Infect Drug Resist 2021 14:4207-4214.
20.Takano K, Hariu M, Watanabe Y, Seki M. Detection of representative mutant strains and a prolonged case infected by SARS-CoV-2 with spike 69/70 deletion in Japan. Infect Drug Resist 2021 14:2579-2581
21.Takano K, Shimada D, Imai H, Hariu M, Kamioka Y, Watanabe Y,Seki M. Severe pulmonary Mycobacterium abscessus cases due to co-infection with other microorganisms well-treated by clarithromycin and sitafloxacin in Japan. Int Med Case Rep J 2021 14, 465-470. DOI https://doi.org/10.2147/IMCRJ.S321969
22.Hariu M, Watanabe Y, Shimada D, Imai H, Takano K, Kamioka Y, Seki M. A household Microsporum canis dermatophytosis suggested by matrix-assisted laser desorption / ionization time-of-flight mass spectrometry analysis. Am J Case Rep 2021 DOI:10.12659/AJCR.930713
23.Imai H, Watanabe Y , Shimada D, Suzuki J, Endo S, Kaku M, Seki M. Utility of Cell-Direct Polymerase Chain Reaction-based Nucleic Acid Lateral Flow Immunoassay for the Rapid Detection of Bacterial Pathogens of Suspected Sepsis cases. Infect Drug Resist 2021;14:5137-5144.
1.Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N. A nationwide questionaire survey of clinic on antimicrobial stewardship in Japan. J Infect Chemother 2020; 26(2):149-156
2.Uchida Y, Uemura H, Yamaba S, Hamada D, Tarumoto N, Maesaki S, Mochida S. Significance of liver dysfunction associated with decreased hepatic CT attenuation values in Japanese patients with severe COVID-19. J Gastroenterol 2020; 55(11):1098-1106.
3.Tarumoto N, Imai K, NakayamaS, Itoda I, Sakai J, Murakami T, Maesaki S, Hayakawa S, Ohnishi M, Maeda T. A novel peptide nucleic acid-mediated loop-mediated isothermal amplification assay for the detection of mutations in the 23S rRNA gene of Treponema pallidum. J Med Microbiol 2020;69(12):1339-1345.
4.Fukada A, Kitagawa Y, Matsuoka M, Sakai J, Imai K, Tarumoto N, Orihara Y, Kawamura R, Takeuchi S, Maesaki S, Maeda T. Presepsin as a predictive biomarker of severity in COVID-19: A case series. J Med Virol 2020 Jun 12;10.1002/jmv.26164
5.Ogane K, Tarumoto N, Kodana M, Onodera A, Imai K, Sakai J, Kawamura T, Takeuchi S, Murakami T, Mitsutake K, Ikebuchi K, Maesaki S, Maeda T. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Anaerobe 2020 Aug;64:102215.
6.Sakai J, Tarumoto N, Orihara Y, Kawamura R, Kodana M, Matsuzaki N, Matsumura R, Okane K, Kawamura T, Takeuchi S, Imai K, Murakami T, Maesaki S, Maeda T. Evaluation of a high-speed but low-throughput RT-qPCR system for SARS-CoV-2 detection. J of Hosp Infect 2020;105(4):615-618.
7.Kitagawa Y, Orihara Y, Kawamura R, Imai K, Sakai J, Tarumoto N, Matsuoka M, Takeuchi S, Maesaki S, Maeda T. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. J Clin Virol 2020; 129: 104446.
8.Imai K, Tabata S, Ikeda M, Noguchi S, Kitagawa Y, Matuoka M, Miyoshi K, Tarumoto N, Sakai J, Ito T, Maesaki S, Tamura K, Maeda T. Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19. J Clin Virol 2020; 128: 104393.
9.Imai K, Nemoto R, Kodana M, Tarumoto N, Sakai J, Kawamura T, Ikebuchi K, Mitsutake K, Murakami T, Maesaki S, Fujiwara T, Hayakawa S, Hoshino T, Seki M, Maeda T. Rapid and Accurate Species Identification of Mitis Group Streptococci Using the MinION Nanopore Sequencer. Front Cell Infect Microbiol 2020; 10: 11.
10.Watanabe N, Kobayashi K, Koyama S, Tabira M, Matsuno J, Taji Y, Akuzawa Y, Ishikawa M, Maeda T, Imai K, Tarumoto N, Asou N, Mitsutake K, Ebihara Y. Bloodstream infection by multidrug-resistant Streptococcus oralis in a leukemic patient with febrile neutropenia after hematopoietic stem cell transplantation. Transpl Infect Dis 2020; 22(2): e13246.
11.Kosaka A, Sakamoto N, Hikone M, Imai K, Ota M, Washino T, Maeda T, Iwabuchi S. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis. Intern Med 2020; 59(9): 1227-30.
12.Tabata S, Imai K, Kawano S, Ikeda M, Kodama K, Miyoshi K, Obinata H, Mimura, Kodera T, Kitagaki M, Sato M, Suzuki S, Ito T, Uwabe Y, Tamura K. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.Lancet Infect Dis 2020 20(9):1043-1050
12.Seki M.Trends in the management of infectious disease in the SARS-CoV-2 era: A pathophysiological comparison of COVID-19 and influenza. World J Virol 2021 DOI https://dx.doi.org/10.5501/wjv.v10.i2.62
13.Seki M.Editorial-Lessons from the nationwide surveillance of SARS-CoV-2 surges in Japan JMA Journal 2021 DOI: 10.31662/jmaj.2021-0091
・ Imai K, Ishibashi N, Kodana M, Tarumoto N, Sakai J, Kawamura T, Takeuchi S, Taji Y, Ebihara Y, Ikebuchi K, Murakami T, Maeda T, Mitsutake K, Maesaki S. Clinical characteristics in blood stream infections caused by Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae: a comparative study, Japan, 2014-2017. BMC Infect Dis. 2019; 19:946.
・ Sakai J, Imanaka K, Kodana M, Ohgane K, Sekine S, Yamamoto K, Nishida Y, Kawamura T, Matsuoka T, Maesaki S, Oka H, Ohno H. Infective endocarditis caused by Capnocytophaga canimorsus; a case report. BMC Infect Dis. 2019 ; 19:927.
・ Sakai J, Tarumoto N, Kodana M, Ashikawa S, Imai K, Kawamura T, Ikebuchi K, Murakami T, Mitsutake K, Maeda T, Maesaki S. An identification protocol for ESBL-producing Gram-negative bacteria bloodstream infections using a MinION nanopore sequencer. J Med Microbiol. In Press.
・ Imai K, Tarumoto N, Tachibana H, Hanabusa A, Sakai J, Yokota K, Mimura T, Maesaki S. Endogenous endophthalmitis secondary to septic arthritis caused by group A Streptococcus infection: A case report and literature review. J Infect Chemother. In Press.
・ Imai K, Misawa K, Osa M, Tarumoto N, Sakai J, Mikita K, Sayama Y, Fujikura Y, Kawana A, Murakami T, Maesaki S, Miura S, Maeda T. Chagas disease: a report of 17 suspected cases in Japan, 2012-2017. Trop Med Health 2019;47:38.
・ Imai K, Tamura K, Tanigaki T, Takizawa M, Nakayama E, Taniguchi T, Okamoto M, Nishiyama Y, Tarumoto N, Mitsutake K, Murakami T, Maesaki S, Maeda T. Whole Genome Sequencing of Influenza A and B Viruses With the MinION Sequencer in the Clinical Setting: A Pilot Study. Front Microbiol 2018;9:2748.
・ Ashikawa S, Tarumoto N, Imai K, Sakai J, Kodana M, Kawamura T, Ikebuchi K, Murakami T, Mitsutake K, Maesaki S, Maeda T. Rapid identification of pathogens from positive blood culture bottles with the MinION nanopore sequencer. Journal of Medical Microbiology 2018;67:1589-1595.
・ Imai K, Tarumoto N, Runtuwene LR, Sakai J, Hayashida K, Eshita Y, Maeda R, Tuda J, Ohno H, Murakami T, Maesaki S, Suzuki Y, Yamagishi J, Maeda T. An innovative diagnostic technology for the codon mutation C580Y in kelch13 of Plasmodium falciparum with MinION nanopore sequencer. Malaria Journal2018;17(1):217.
・ Misawa K, Tarumoto N, Tamura S, Osa M, Hamamoto T, Yuki A, Kouzaki Y, Imai K, Ronald RL, Yamaguchi T, Murakami T, Maesaki S, Suzuki Y, Kawana A, Maeda T. Single nucleotide polymorphisms in genes encoding penicillin-binding proteins in β-lactamase-negative ampicillin-resistant Haemophilus influenzae in Japan. BMC Research Notes 2018;11(1):53.
・ Imai K, Tarumoto N, Amo K, Takahashi M, Sakamoto N, Kosaka A, Kato Y, Mikita K, Sakai J, Murakami T, Suzuki Y, Maesaki S, Maeda T. Non-invasive diagnosis of cutaneous leishmaniasis by the direct boil loop-mediated isothermal amplification methodand MinION nanopore sequencing. Parasitology International2018;67(1):34-7.
・ Tarumoto N, Kodana M, Watanabe N, Sakai J, Imai K, Yamaguchi T, Taji Y, Ebihara Y, Murakami T, Maeda T, Mitsutake K, Maesaki S. First report of the isolation of blaIMI-1-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016. Journal of Infection and Chemotherapy 2018;24:941-943.
・ Tarumoto N, Sakai J, Sujino K, Yamaguchi T, Ohta M, Yamagishi J, RuntuweneLR, Murakami T, SuzukiY, Maeda T, Maesaki S：Use of the Oxford Nanopore MinION sequencer for MLST genotyping of vancomycin-resistant enterococci. Journal of Hospital Infection 2017;96:296-298.
・ Tamura S, Maeda T, Misawa K, Osa M, Hamamoto T, Yuki A, Imai K, Mikita K, Morichika K, Kawana A, Matsumoto H, Nonoyama S：Development of a highly resolved loop-mediated isothermal amplification method to detect the N526K ftsI mutation of β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Journal of Microbiological Methods 2017;141:108-114.
・ Sakai J, Maeda T, Tarumoto N, Misawa K, Tamura S, Imai K, Yamaguchi T, Iwata S, Murakami T, Maesaki S：A novel detection procedure for mutations in the 23S rRNA gene of Mycoplasma pneumoniae with peptidenucleic acid-mediated loop-mediated isothermal amplification assay. Journal of Microbiological Methods 2017;141:90-96.
・ Imai K, Tarumoto N, Misawa K, Runtuwene LR, Sakai J, Hayashida K, Eshita Y, Maeda R, Tuda J, Murakami T, Maesaki S, Suzuki Y, Yamagishi J, Maeda T. A novel diagnostic method for malaria using loop-mediated isothermal amplification (LAMP) and MinION nanopore sequencer. BMC Infectious Disease2017;17(1):621.
・ Tachi K, Sato A, Kouzaki Y, Maeda T, Kawana A, Asano T. A case of Bacillus Calmette-Guérin cystitis diagnosed with a novel loop-mediated Isothermal amplification method. Urological Case Report2017;14:24-26.
・ Suzuki T, Hara N, Osa M, Misawa K, Imai K, Fujikura Y, Maeda T, Sonehara W, Kawana A. Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports. Journal of Pharmaceutical Health Care and Sciences 2017;3:23.
・Osawa M, Mine S, Ota S, Kato K, Sekizuka T, Kuroda M, Kataoka M, Fukumoto H, Sato Y, KannoT, Hasegawa H, Ueda K, Fukayama M, Maeda T, Kanoh S, Kawana A, Fujikura Y, Katano H. Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi’s sarcoma-associated herpesvirus. Infectious Agents and Cancer 2016;11:37.
・ Imai K, Nakayama E, Maeda T, Mikita K, Kobayashi Y, Mitarai A, Honma Y, Miyake S, Kaku K, Miyahira Y, Kawana A：Chikungunya fever in Japan imported from the Caribbean islands. Japanese Journal of Infectious Diseases 2016;69:151-153.
・ Osa M, Maeda T, Misawa K, Imai K, Fujikura Y, Kawana A. Clinical response to liposomal doxorubicin and rituximab in HHV-8-associated multicentric Castleman’s disease in an HIV-positive patient Journal of Infection and Chemotherapy 2016;22:804-807.
・ Imai K, Misawa K, Matsumura T, Fujikura Y, Mikita K, Tokoro M, Maeda T, Kawana A. Progressive HIV-associated cholangiopathy in an HIV patient treated with combination antiretroviral therapy. Internal Medicine 2016;55:2881-2884.
・ Ota S, Maki Y, Mori K, Hamamoto T, Kurokawa A, Ishihara M, Yamamoto T, Imai K, Misawa K, Yuki A, Fujikura Y, Maeda T, Kawana A. Diagnosis of imported Ugandan typhoid fever based on local outbreak information: A case report. Journal of Infection and Chemotherapy 2016;22:770-773.
Academic Meeting
・ Tarumoto N. A novel detection procedure for mutations in the 23S rRNA gene of Treponema pallidum with a peptide nucleic acid-mediated loop-mediated isothermal amplification assay. ECCMID (Amsterdam, Netherlands) 2019.
・ Sakai J. A method using the MinION nanopore sequencer for detecting bacteria and ESBL-producing species in the bloodstream. ECCMID (Amsterdam, Netherlands) 2019.
・ Maeda T. Evaluation of MinION sequencer for identification of pathogens from positive blood cultures in bloodstream infections. 3rd Technology Seminar on the MinION sequencing. (Manado, Indonesia) 2018.
・ Maeda T. Practical uses of MinION sequencer at clinical settings in Japan. 2nd Technology Seminar on the MinION sequencing. (Bangkok, Thailand) 2017.
・ Maeda T. Innovation of MinION nanopore sequencing for molecular identification of protozoal pathogens. Boliviano Japones De Gastroenterologia. (Santa Cruz, Plurinational State of Bolivia) 2016.
・ Imai K. A novel diagnostic method for Malaria using loop mediated isothermal amplification (LAMP) and MinION nanopore sequencer. IDWeek (San diego, USA) 2017.